about
Prevalence of pathogenetic MC4R mutations in Italian children with early onset obesity, tall stature and familial history of obesity.Multiple pituitary hormone deficiency: management of puberty for optimal auxological results.Hypogonadism and pubertal development in Prader-Willi syndrome.[Miocamycin: multicenter clinical study in patients with bacterial infections of the upper respiratory tract]Whole genome SNP genotyping and exome sequencing reveal novel genetic variants and putative causative genes in congenital hyperinsulinism.Inhaled corticosteroids in childhood asthma: long-term effects on growth and adrenocortical function.Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome.Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later.The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey.A rare genetic disorder causing persistent severe neonatal hypoglycaemia the diagnostic workupA "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates.Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.Metabolic syndrome in adult patients with Prader-Willi syndrome.Esophageal impedance and esophagitis in children: any correlation?Genetic analysis of Italian patients with congenital hyperinsulinism of infancy.[Treatment of childhood obesity].Behind the (impedance) baseline in children.Esophageal impedance baseline is age dependent.Short-term effects of growth hormone treatment on the upper airways of non severely obese children with Prader-Willi syndrome.Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study.Low mean impedance in 24-hour tracings and esophagitis in children: a strong connection.Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndromePOI: A Score to Modulate GH Treatment in Children with Prader-Willi SyndromeMetabolic syndrome in children with Prader–Willi syndrome: the effect of obesityThe Italian National Survey for Prader–Willi syndrome: An epidemiologic study[Experience in diet therapy of child obesity]The influence of dietary education in diabetic children[Intestinal invagination. Analysis of cases]Hyponatremia and seizures during desmopressin acetate treatment in hypothyroidism[Nutrition in school-age children: a survey at a nursery school]Evidence for the presence of the pituitary insulin secretagogue beta-cell trophin in human plasma[Obesity and mental disorders in childhood]Hypothyroidism and sodium valproateThe Turner phenotype and the different types of human X isochromosomeEffect of purified somatomedins on thymidine incorporation into lectin-activated human lymphocytesGrowth hormone dependency of the effect of human serum on thymidine uptake by lectin-activated human lymphocytesLHRH test in Bartter's syndrome before and during treatment with prostaglandin synthesis inhibitors[Hyperthyroidism in children (author's transl)]Childhood obesity: results of a multicenter study of obesity treatment in Italy[Prader-Willi syndrome]
P50
Q33417911-AC1A9710-04B9-4620-85AC-81A233F0C97AQ34350782-79B3C86A-651F-42EA-8A43-F0721B8BB500Q34532776-02EF6666-19D4-4F25-BEA6-3D0C17D44AA4Q34687403-D6A9DBB3-A256-4C74-BED8-56F464457DF8Q34837985-A4CE7D3D-6D2B-445C-902B-EEC2312981A3Q35135367-7A4B8821-3619-4E13-A558-0AB25DD9A175Q39471082-09CAF774-E297-4A94-B831-B41A17DC040DQ40284644-FBD84B7B-ADA7-41F2-AE03-ED2120616C14Q40846148-1A27A34A-FD6A-4E15-85AE-8A01F0744D08Q42018371-A81BFBA9-A010-4BAE-946A-D1948CF86A26Q42488995-3A134A37-AFE8-4519-B093-E6865777FBF0Q43216755-DD831C96-5922-464B-99A5-3CBC77E116E5Q43429393-7A625BE9-CCC5-4B6E-92AF-CF4D0FF2DB12Q43686279-C36C9411-A835-4967-A9EC-9FCBD888CC89Q43916901-D0B2A2BF-521F-4C84-B4FD-2153AB094957Q44649281-1EE7B481-84B5-4AE0-8A47-599225EDA72CQ44684830-962AEA39-4327-4623-B5EC-646664D61DB6Q45841579-9D6A4005-7311-4F46-8293-C9D33E9BB052Q45981890-56FCFBF9-7A16-4A0F-B8FD-C7693EECD004Q46793013-3C92E905-92F2-4ACF-9047-4A5EBC726A2CQ51020289-BF2FE644-A1F1-4AA2-8C2B-71A2EF9FCA95Q58493398-6BD3C7D2-7FBC-4484-B4CF-EE8CC4608EA7Q58493419-F03A97CF-25D4-49D3-94A7-2BE43C122942Q58493426-B5844800-192A-43B1-9741-998A51BC97A8Q58493485-9A220183-B429-4FE6-8142-DFEABB94FBB3Q68064069-8C6FDE3E-302D-4DCF-83CB-AC863E05608FQ68581033-F618257A-F386-40FB-957B-AF9B12F4D554Q68683432-4E489EFE-7E37-4E8B-98C6-D8110B5EEB0AQ68761196-1CBBC27B-4AB2-4324-A176-97DE6A8997B3Q69466885-480F4C37-00F7-4AC3-9850-A6754C00BE09Q70146399-66A5AC8F-B038-470E-B952-D8E9F47E9FD5Q70286098-BCE40777-AA49-4A00-895F-DC15E5F334E1Q70456097-559ABAD2-1736-4B34-BCC8-DDED0AFE1436Q70542219-E6E30EC3-3A72-48E8-BBBB-E5C666F45287Q71227997-F465DDD3-20D9-4F71-8FCF-D6A81862EF3FQ71259484-C58D7728-6642-44E4-A3AF-83BB04769D5BQ71577767-92A7FA9F-2A9E-4CFA-96A5-24401EF8AD74Q72650737-74FD0433-B940-476B-9496-A8BE2F4693FDQ73335494-E0D95048-C3D1-4160-984C-B179E52E059EQ73381466-D52E6B33-C12B-45D8-B4F1-EA880AEFDE29
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A Salvatoni
@ast
A Salvatoni
@en
A Salvatoni
@es
A Salvatoni
@nl
type
label
A Salvatoni
@ast
A Salvatoni
@en
A Salvatoni
@es
A Salvatoni
@nl
prefLabel
A Salvatoni
@ast
A Salvatoni
@en
A Salvatoni
@es
A Salvatoni
@nl
P106
P1153
7003484322
P31
P496
0000-0002-9604-810X